Search

744 whole blood samples of normal subjects from Germany collected in 1989-1998 have been analyzed for polychlorinated dibenzo-p-dioxins (PCDD) and dibenzofurans (PCDF) by capillary gas chromatography/high resolution mass spectrometry. Over the examined time period a continuous decrease of the PCDD/F concentrations in human blood was observed. The mean levels found were 43.7 pg I-TEq/g (lipid basis) in 1989 and 20.7 pg I-TEq/g (lipid basis) in 1996/98 [median: 42.2 and 19.4]. The reduction to about the half was found for most congeners. Each one-year subset of the collective and the entire collective shows a positive correlation of the PCDD/F blood levels with age for most of the congeners, the sum values and the calculated toxicity equivalents. For statistical evaluation a multiplicative model was used: Concentration = A x Age(B). The correlation is mostly pronounced for lower chlorinated PCDD and for 2,3,4,7,8-PentaCDF. The PCDD/F concentrations in human blood in relation to the year of examination and the age of the subjects can be described by a linear model: I-TEq [pg/g (lipid basis)] = 6176 - 3.097 x Year + 0.6482 x Age or by a multiplicative model: I-TEq [pg/g(lipid basis)] = 10(89.08-0.04415 x Year + 0.008468 x Age).

A mass balance of human dietary PCDD/F-intake and fecal PCDD/F-excretion was carried out. The participants of the study were seven male and seven female adults between the ages of 24 to 64 years, living in North Rhine-Westphalia, Germany. The PCDD/F-intake was measured using the duplicate method. Sampling time of each food duplicate covered three days. The fecal PCDD/F-excretion was measured by collecting the feces which corresponded to the food duplicates. The mean daily dietary PCDD/F-intake was 49 pg I-TEq/d (range: 23-96 pg I-TEq/d) and therewith lower than that estimated in the past. The mean daily fecal PCDD/F-excretion was 98 pg I-TEq/d (40-200 pg I-TEq/d). This is twice the amount of the PCDD/F-intake. The fecal excretion of OCDD was especially higher than the dietary intake (mean: 7 fold, range: 1.2-21 fold). The differences between PCDD/F-intake and PCDD/F-excretion may be caused by a reduction of the body burden as a consequence of decreasing PCDD/F-intake. Other explanations were additional sources of exposure to PCDD/F or de novo formation of PCDD/F in the human body.

Chlorophenols (CP) are transformed in vitro to polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/F) by a biochemical-catalyzed oxidation. This is shown for 2,4,5-tri-, 2,3,4,6-tetra-and pentachlorophenol with myeloperoxidase recovered from human leucocytes in the presence of hydrogen peroxide. The yield, the reaction, and the PCDD/F-pattern found depend on the CP. The formation rates are in the micromol-per-mol range for all substrates. The experiments confirm the suspicion that a biochemical formation of PCDD/F from precursors such as CPs can take place in the human body and that this metabolic pathway may lead to a higher inner exposure with PCDD/F than is now assumed.